tradingkey.logo

Eli Lilly Estimates Q1 2025 Acquired IPR&D Charges Approximately $1.72 To EPS

ReutersApr 10, 2025 9:25 PM

- Eli Lilly and Co LLY.N:

  • ELI LILLY: ESTIMATED Q1 2025 ACQUIRED IN-PROCESS RESEARCH AND DEVELOPMENT CHARGES APPROXIMATELY $1.72 TO EPS

  • ELI LILLY: ESTIMATED Q1 2025 ACQUIRED IPR&D CHARGES APPROXIMATELY $1.57 BILLION ON A PRE-TAX BASIS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI